Qube Research & Technologies Ltd: EVLV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Qube Research & Technologies Ltd on EVLV, newest first. How the timeline and the estimate are built.
Qube Research & Technologies Ltd held 1,634,953 EVLV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 1,634,953 sharesChange vs previous 13F +470,435 shares
0.01% of the 13F portfolio, value $9,482,727.
13F-HR 0001729829-26-000014 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,164,518 sharesChange vs previous 13F +309,913 shares
0.01% of the 13F portfolio, value $7,045,334.
13F-HR 0001729829-26-000004 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 854,605 sharesChange vs previous 13F +156,113 shares
0.01% of the 13F portfolio, value $6,118,972.
13F-HR 0001729829-26-000002 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 698,492 sharesChange vs previous 13F +533,773 shares
0.01% of the 13F portfolio, value $5,273,615.
13F-HR 0001729829-25-000053 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 164,719 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,027,847.
13F-HR 0001729829-25-000050 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).